Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Embryonal Tumor, NOS”

2,632 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,632 results

Not applicableEnrolling By InvitationNCT02270567
What this trial is testing

RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide

Who this might be right for
Neuroendocrine TumorCarcinoidNeuroendocrine Carcinoma
Wren Laboratories LLC 400
Testing effectiveness (Phase 2)Ended earlyNCT01723813
What this trial is testing

Peptide Vaccinations Plus GM-CT-01 in Melanoma

Who this might be right for
Metastatic Melanoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 6
Testing effectiveness (Phase 2)Study completedNCT00453310
What this trial is testing

Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment

Who this might be right for
Extragonadal Germ Cell TumorOvarian CancerTeratoma+1 more
Memorial Sloan Kettering Cancer Center 10
Not applicableEnrolling By InvitationNCT06388252
What this trial is testing

Electrochemotherapy Induces Changes in the Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Patients With Cutaneous Melanoma

Who this might be right for
Cutaneous Malignant Melanoma
Institute of Oncology Ljubljana 10
Testing effectiveness (Phase 2)Study completedNCT00012038
What this trial is testing

Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Not applicableStudy completedNCT04476082
What this trial is testing

Nutrition in Gastrointestinal Tumors

Who this might be right for
Pancreatic CancerOesophageal CancerColon Cancer+7 more
University Medicine Greifswald 66
Early research (Phase 1)WithdrawnNCT05341947
What this trial is testing

Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Jeremy Rudnick, M.D
Testing effectiveness (Phase 2)Looking for participantsNCT06299891
What this trial is testing

Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity

Who this might be right for
Hypothalamic ObesityHypothalamic TumorCraniopharyngioma
Seattle Children's Hospital 24
Testing effectiveness (Phase 2)Study completedNCT00006268
What this trial is testing

Immunotoxin Therapy in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Not applicableLooking for participantsNCT06887348
What this trial is testing

Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

Who this might be right for
MelanomaMetastatic MelanomaAdvanced Solid Tumor+1 more
Replimune Inc. 50
Not applicableStudy completedNCT02902822
What this trial is testing

Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo

Who this might be right for
ErysipelasImpetigoHerpes Zoster+7 more
Centro Studi Gised 461
Testing effectiveness (Phase 2)Looking for participantsNCT06395402
What this trial is testing

177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry

Who this might be right for
Neuroendocrine TumorsNeuroendocrine Tumor Grade 1Neuroendocrine Tumor Grade 2
University of Iowa 120
Early research (Phase 1)Looking for participantsNCT06041516
What this trial is testing

Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors and Carcinomas

Who this might be right for
Neuroendocrine CarcinomasNeuroendocrine TumorsCarcinoma, Neuroendocrine+2 more
National Cancer Institute (NCI) 70
Early research (Phase 1)Study completedNCT01294735
What this trial is testing

Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)

Who this might be right for
Recurrence of Solid TumorGlioblastoma MultiformeMelanoma
Merck Sharp & Dohme LLC 19
Not applicableStudy completedNCT04039672
What this trial is testing

Interest of Tumor Replicates in Avian Embryo to Model Therapeutic Effects of BRAFi/MEKi in BRAF Mutated Melanoma

Who this might be right for
Melanoma
Hospices Civils de Lyon 10
Testing effectiveness (Phase 2)Looking for participantsNCT06070012
What this trial is testing

Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma

Who this might be right for
Uveal Melanoma
Diwakar Davar 44
Early research (Phase 1)WithdrawnNCT00458744
What this trial is testing

Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaLymphoma+1 more
Children's Oncology Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT04083599
What this trial is testing

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

Who this might be right for
Malignant Solid TumorNon-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+3 more
Genmab 350
Not applicableLooking for participantsNCT07072143
What this trial is testing

An International Study on Pediatric Patients With Rare Tumors.

Who this might be right for
Paraganglioma/ PhaeochromocytomaMelanoma and Other Malignant Neoplasms of SkinGastrointestinal Stromal Tumor (GIST)+11 more
Azienda Ospedaliera di Padova 6,250
Testing effectiveness (Phase 2)Ended earlyNCT02771626
What this trial is testing

Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Clear Cell Renal Cell Carcinoma (ccRCC)MelanomaNon-small Cell Lung Cancer (NSCLC)
Calithera Biosciences, Inc 118
Load More Results